Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription Articles published in J Autoimmun Retrieve available abstracts of 238 articles: HTML format

Single Articles

April 2024
1. WORZNER K, Zimmermann J, Buhl R, Desoi A, et al
   Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype.
   J Autoimmun. 2024;144:103174.
   PubMed     Abstract available
   
   
   
2. STUCCHI A, Maspes F, Montee-Rodrigues E, Fousteri G, et al
   Engineered Treg cells: The heir to the throne of immunotherapy.
   J Autoimmun. 2024;144:102986.
   PubMed     Abstract available
   
   
   March 2024
3. DZIEDZIC A, Michlewska S, Jozwiak P, Debski J, et al
   Quantitative and structural changes of blood platelet cytoskeleton proteins in multiple sclerosis (MS).
   J Autoimmun. 2024;145:103204.
   PubMed     Abstract available
   
   
   
4. WANG Y, Wang S, Liu W, Gu H, et al
   Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice.
   J Autoimmun. 2024;145:103205.
   PubMed     Abstract available
   
   
   
5. HUANG W, Jin T, Zheng W, Yin Q, et al
   Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases.
   J Autoimmun. 2024;145:103188.
   PubMed     Abstract available
   
   
   
6. CHAVULA T, To S, Smith J, Pedroza M, et al
   CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus.
   J Autoimmun. 2024;145:103197.
   PubMed     Abstract available
   
   
   February 2024
7. BONACINI M, Rossi A, Ferrigno I, Muratore F, et al
   miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.
   J Autoimmun. 2024;144:103186.
   PubMed     Abstract available
   
   
   
8. FISCHER S, Meisinger C, Freuer D
   Autoimmune diseases and female-specific cancer risk: A systematic review and meta-analysis.
   J Autoimmun. 2024;144:103187.
   PubMed     Abstract available
   
   
   
9. VERGOUWEN DPC, van Beek AA, de Hoog J, de Boer JH, et al
   The enigma of sclera-specific autoimmunity in scleritis.
   J Autoimmun. 2024;144:103178.
   PubMed     Abstract available
   
   
   
10. HOXHA A, Perin N, Lovisotto M, Calligaro A, et al
    Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study.
    J Autoimmun. 2024;144:103180.
    PubMed     Abstract available
    
    
    
11. NEYS SFH, Heutz JW, van Hulst JAC, Vink M, et al
    Aberrant B cell receptor signaling in circulating naive and IgA(+) memory B cells from newly-diagnosed autoantibody-positive rheumatoid arthritis patients.
    J Autoimmun. 2024;143:103168.
    PubMed     Abstract available
    
    
    
12. LORENZON R, Ribet C, Pitoiset F, Aractingi S, et al
    The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
    J Autoimmun. 2024;144:103172.
    PubMed     Abstract available
    
    
    
13. TAIEB D, Moyon Q, Lhote R, Annesi-Maesano I, et al
    Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases.
    J Autoimmun. 2024;144:103173.
    PubMed     Abstract available
    
    
    January 2024
14. ZHONG T, Li X, Lei K, Tang R, et al
    CXCL12-CXCR4 mediates CD57(+) CD8(+) T cell responses in the progression of type 1 diabetes.
    J Autoimmun. 2024;143:103171.
    PubMed     Abstract available
    
    
    
15. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
    Older age of celiac disease diagnosis and risk of autoimmune disease: A nationwide matched case-control study.
    J Autoimmun. 2024;143:103170.
    PubMed     Abstract available
    
    
    
16. LINDELOF L, Rantapaa-Dahlqvist S, Lundtoft C, Sandling JK, et al
    A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile.
    J Autoimmun. 2024;143:103166.
    PubMed     Abstract available
    
    
    
17. LI Y, Tang C, Vanarsa K, Thai N, et al
    Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis.
    J Autoimmun. 2024;143:103165.
    PubMed     Abstract available
    
    
    
18. REUSCHLE Q, Van Heddegem L, Bosteels V, Moncan M, et al
    Loss of function of XBP1 splicing activity of IRE1alpha favors B cell tolerance breakdown.
    J Autoimmun. 2024;142:103152.
    PubMed     Abstract available
    
    
    
19. LIBERATORE J, Nguyen Y, Hadjadj J, Cohen P, et al
    Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study.
    J Autoimmun. 2024;142:103130.
    PubMed     Abstract available
    
    
    
20. KELLY S, Jackson KJ, Peters TJ, Suan D, et al
    Isolation and characterisation of PR3-specific B cells and their immunoglobulin sequences.
    J Autoimmun. 2024;142:103129.
    PubMed     Abstract available
    
    
    
21. REYNOLDS JA, Li Y, Herlitz L, Mohan C, et al
    Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum.
    J Autoimmun. 2024;142:103134.
    PubMed     Abstract available
    
    
    
22. XU C, Zhang T, Wang H, Zhu L, et al
    Integrative single-cell analysis reveals distinct adaptive immune signatures in the cutaneous lesions of pemphigus.
    J Autoimmun. 2024;142:103128.
    PubMed     Abstract available
    
    
    
23. MERINO-VICO A, van Hamburg JP, Tuijnenburg P, Frazzei G, et al
    Targeting NF-kappaB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis.
    J Autoimmun. 2024;142:103133.
    PubMed     Abstract available
    
    
    December 2023
24. PENG X, Li H, Zhu L, Zhao S, et al
    Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis.
    J Autoimmun. 2023;143:103160.
    PubMed     Abstract available
    
    
    
25. GAO L, Zhang W, Zhang L, Gromova B, et al
    Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis.
    J Autoimmun. 2023;143:103162.
    PubMed     Abstract available
    
    
    
26. BENDER C, Muller P, Tondello C, Horn J, et al
    Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.
    J Autoimmun. 2023;143:103161.
    PubMed     Abstract available
    
    
    
27. SOMERS EC, Goodrich JM, Wang L, Harlow SD, et al
    Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) Program.
    J Autoimmun. 2023;142:103137.
    PubMed     Abstract available
    
    
    
28. SHAO T, Hsu R, Rafizadeh DL, Wang L, et al
    The gut ecosystem and immune tolerance.
    J Autoimmun. 2023;141:103114.
    PubMed     Abstract available
    
    
    
29. GUO Z, Yiu N, Hu Z, Zhou W, et al
    Alterations of fecal microbiome and metabolome in pemphigus patients.
    J Autoimmun. 2023;141:103108.
    PubMed     Abstract available
    
    
    November 2023
30. GREIGERT H, Ramon A, Genet C, Cladiere C, et al
    Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.
    J Autoimmun. 2023;142:103151.
    PubMed     Abstract available
    
    
    
31. YASUDA K, Shimodan S, Maehara N, Hirota A, et al
    AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions.
    J Autoimmun. 2023;142:103149.
    PubMed     Abstract available
    
    
    
32. CARMONA EG, Callejas-Rubio JL, Raya E, Rios-Fernandez R, et al
    Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4(+) T cells in giant cell arteritis.
    J Autoimmun. 2023;142:103124.
    PubMed     Abstract available
    
    
    October 2023
33. KISHIMOTO TK, Fournier M, Michaud A, Rizzo G, et al
    Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
    J Autoimmun. 2023;140:103125.
    PubMed     Abstract available
    
    
    
34. LI Y, Song H, Meng X, Li R, et al
    Autoimmune pancreatitis type 2 (idiopathic duct-centric pancreatitis): A comprehensive review.
    J Autoimmun. 2023;140:103121.
    PubMed     Abstract available
    
    
    
35. ERDEI E, O'Donald ER, Luo L, Enright K, et al
    Comparison of circulating and excreted metals and of autoimmunity between two Great Plains Tribal communities.
    J Autoimmun. 2023 Oct 7:103117. doi: 10.1016/j.jaut.2023.103117.
    PubMed     Abstract available
    
    
    
36. DU Y, Brodeur KE, Hsu E, Chen L, et al
    In cis "benign" SOCS1 variants linked to enhanced interferon signaling and autoimmunity.
    J Autoimmun. 2023;140:103119.
    PubMed     Abstract available
    
    
    September 2023
37. ZHANG D, Kinloch AJ, Srinath A, Shenkar R, et al
    Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469].
    J Autoimmun. 2023 Sep 23:103116. doi: 10.1016/j.jaut.2023.103116.
    PubMed    
    
    
    
38. WINANS T, Oaks Z, Choudhary G, Patel A, et al
    mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
    J Autoimmun. 2023;140:103112.
    PubMed     Abstract available
    
    
    
39. TERZIROLI BERETTA-PICCOLI B, Buescher G, Dalekos G, Zachou K, et al
    Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis.
    J Autoimmun. 2023;140:103113.
    PubMed     Abstract available
    
    
    
40. LIN Y, Sakuraba S, Massilamany C, Reddy J, et al
    Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues.
    J Autoimmun. 2023;140:103094.
    PubMed     Abstract available
    
    
    
41. GRAVER JC, Jiemy WF, Altulea DHA, van Sleen Y, et al
    Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis.
    J Autoimmun. 2023;140:103111.
    PubMed     Abstract available
    
    
    
42. LIU X, Liu M, Zhao M, Li P, et al
    Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges.
    J Autoimmun. 2023 Sep 8:103109. doi: 10.1016/j.jaut.2023.103109.
    PubMed     Abstract available
    
    
    
43. BAE HR, Shin SK, Yoo JH, Kim S, et al
    Chronic inflammation in high-fat diet-fed mice: Unveiling the early pathogenic connection between liver and adipose tissue.
    J Autoimmun. 2023;139:103091.
    PubMed     Abstract available
    
    
    
44. JIWRAJKA N, Toothacre NE, Beethem ZT, Sting S, et al
    Impaired dynamic X-chromosome inactivation maintenance in T cells is a feature of spontaneous murine SLE that is exacerbated in female-biased models.
    J Autoimmun. 2023;139:103084.
    PubMed     Abstract available
    
    
    
45. NATSUMOTO B, Shoda H, Nagafuchi Y, Ota M, et al
    Functional evaluation of rare OASL variants by analysis of SLE patient-derived iPSCs.
    J Autoimmun. 2023;139:103085.
    PubMed     Abstract available
    
    
    
46. FLOREZ-BARROS F, Bearder S, Pavlidis P, Robson MG, et al
    Antimyeloperoxidase antibodies modulate inflammatory responses and activate profibrotic pathways in human monocytes.
    J Autoimmun. 2023;139:103060.
    PubMed     Abstract available
    
    
    August 2023
47. POYSTI S, Silojarvi S, Brodnicki TC, Catterall T, et al
    Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
    J Autoimmun. 2023;140:103090.
    PubMed     Abstract available
    
    
    July 2023
48. ALLEN PC, Roberts K, Rubio JE, Tiwari HK, et al
    Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.
    J Autoimmun. 2023;139:103089.
    PubMed     Abstract available
    
    
    
49. MARTIN MONREAL MT, Hansen BE, Iversen PF, Enevold C, et al
    Citrullination of myelin basic protein induces a Th17-cell response in healthy individuals and enhances the presentation of MBP85-99 in patients with multiple sclerosis.
    J Autoimmun. 2023;139:103092.
    PubMed     Abstract available
    
    
    
50. ZHAO J, Li L, Feng X, Gao C, et al
    TIGIT-Fc fusion protein alleviates murine lupus nephritis through the regulation of SPI-B-PAX5-XBP1 axis-mediated B-cell differentiation.
    J Autoimmun. 2023;139:103087.
    PubMed     Abstract available
    
    
    
51. PUDJIHARTONO N, Ho D, Golovina E, Fadason T, et al
    Juvenile idiopathic arthritis-associated genetic loci exhibit spatially constrained gene regulatory effects across multiple tissues and immune cell types.
    J Autoimmun. 2023;138:103046.
    PubMed     Abstract available
    
    
    
52. PASSERI L, Andolfi G, Bassi V, Russo F, et al
    Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.
    J Autoimmun. 2023;138:103051.
    PubMed     Abstract available
    
    
    
53. HENSCHEL P, Landwehr-Kenzel S, Engels N, Schienke A, et al
    Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
    J Autoimmun. 2023;138:103057.
    PubMed     Abstract available
    
    
    June 2023
54. KARLSSON J, Wettero J, Potempa LA, Fernandez-Botran R, et al
    Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP.
    J Autoimmun. 2023;139:103073.
    PubMed     Abstract available
    
    
    
55. FRECH M, Danzer H, Uchil P, Azizov V, et al
    Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease.
    J Autoimmun. 2023;139:103071.
    PubMed     Abstract available
    
    
    
56. ALVAREZ-SIERRA D, Rodriguez-Grande J, Gomez-Brey A, Bello I, et al
    Single cell transcriptomic analysis of Graves' disease thyroid glands reveals the broad immunoregulatory potential of thyroid follicular and stromal cells and implies a major re-interpretation of the role of aberrant HLA class II expression in autoimm
    J Autoimmun. 2023;139:103072.
    PubMed     Abstract available
    
    
    
57. ROJAS M, Herran M, Ramirez-Santana C, Leung PSC, et al
    Molecular mimicry and autoimmunity in the time of COVID-19.
    J Autoimmun. 2023;139:103070.
    PubMed     Abstract available
    
    
    
58. VULSTEKE JB, Smith V, Bonroy C, Lenaerts JL, et al
    Autoantibodies against the NineTeen complex and U5 RNP in systemic sclerosis.
    J Autoimmun. 2023;139:103056.
    PubMed     Abstract available
    
    
    May 2023
59. DUVVURI B, Pachman LM, Hermanson P, Wang T, et al
    Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis.
    J Autoimmun. 2023;138:103061.
    PubMed     Abstract available
    
    
    
60. COLOMBO E, Di Dario M, Menon R, Valente MM, et al
    HNF4alpha, SP1 and c-myc are master regulators of CNS autoimmunity.
    J Autoimmun. 2023;138:103053.
    PubMed     Abstract available
    
    
    
61. HUANG W, Rui K, Wang X, Peng N, et al
    The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis.
    J Autoimmun. 2023;138:103049.
    PubMed     Abstract available
    
    
    
62. WANG CW, Chen CB, Lu CW, Chen WT, et al
    Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines.
    J Autoimmun. 2023;138:103054.
    PubMed     Abstract available
    
    
    
63. XIN Y, Huang C, Zheng M, Zhou W, et al
    Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial.
    J Autoimmun. 2023 May 11:103058. doi: 10.1016/j.jaut.2023.103058.
    PubMed     Abstract available
    
    
    
64. ZHANG B, Zhou W, Liu Q, Huang C, et al
    Effects of fecal microbiota transplant on DNA methylation in patients with systemic lupus erythematosus.
    J Autoimmun. 2023 May 11:103047. doi: 10.1016/j.jaut.2023.103047.
    PubMed     Abstract available
    
    
    
65. LINDBLOM J, Toro-Dominguez D, Carnero-Montoro E, Beretta L, et al
    Corrigendum to 'Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus' [J. Autoimmun. 136 (April 2023) 103025].
    J Autoimmun. 2023 May 2:103052. doi: 10.1016/j.jaut.2023.103052.
    PubMed    
    
    
    
66. WANG Q, Wu S, Ye X, Tan S, et al
    Gut microbial signatures and their functions in Behcet's uveitis and Vogt-Koyanagi-Harada disease.
    J Autoimmun. 2023;137:103055.
    PubMed     Abstract available
    
    
    April 2023
67. YANG R, Chen Z, Cai J
    Fecal microbiota transplantation: Emerging applications in autoimmune diseases.
    J Autoimmun. 2023 Apr 26:103038. doi: 10.1016/j.jaut.2023.103038.
    PubMed     Abstract available
    
    
    
68. JIANG Y, Jin X, Chi Z, Bai Y, et al
    Protein phosphatase 2A propels follicular T helper cell development in lupus.
    J Autoimmun. 2023;136:103028.
    PubMed     Abstract available
    
    
    
69. YAMASHITA M, Honda A, Shimoyama S, Umemura M, et al
    Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis.
    J Autoimmun. 2023;136:103027.
    PubMed     Abstract available
    
    
    
70. SPANGMOSE AL, Jorgensen MH, Jakobsen C, Wewer V, et al
    Pre- and perinatal exposures associated with developing pediatric-onset immune-mediated inflammatory disease: A Danish nation-wide cohort study.
    J Autoimmun. 2023;136:103032.
    PubMed     Abstract available
    
    
    March 2023
71. KELLER CW, Adamopoulos IE, Lunemann JD
    Autophagy pathways in autoimmune diseases.
    J Autoimmun. 2023;136:103030.
    PubMed     Abstract available
    
    
    
72. HENSVOLD A, Horuluoglu B, Sahlstrom P, Thyagarajan R, et al
    The human bone marrow plasma cell compartment in rheumatoid arthritis - Clonal relationships and anti-citrulline autoantibody producing cells.
    J Autoimmun. 2023;136:103022.
    PubMed     Abstract available
    
    
    
73. MAURO D, Manou-Stathopoulou S, Rivellese F, Sciacca E, et al
    UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus.
    J Autoimmun. 2023;136:103023.
    PubMed     Abstract available
    
    
    
74. LINDBLOM J, Toro-Dominguez D, Carnero-Montoro E, Beretta L, et al
    Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus.
    J Autoimmun. 2023;136:103025.
    PubMed     Abstract available
    
    
    
75. MORSHED S, Latif R, Davies TF
    Signal responses to neutral TSH receptor antibody - A cycle of damage in the pathophysiology of Graves' disease.
    J Autoimmun. 2023;136:103012.
    PubMed     Abstract available
    
    
    
76. GRECO R, Snowden JA, Knelange NS, Tridello G, et al
    Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases.
    J Autoimmun. 2023;136:103024.
    PubMed     Abstract available
    
    
    February 2023
77. ALVAREZ-SIERRA D, Sanchez-Gaona N, Cruz Cobo M, Escriche A, et al
    Thyroid cells from normal and autoimmune thyroid glands suppress T lymphocytes proliferation upon contact revealing a new regulatory inhibitory type of interaction independent of PD1/PDL1.
    J Autoimmun. 2023;136:103013.
    PubMed     Abstract available
    
    
    
78. BRONZ G, Gianini J, Passi AG, Rizzi M, et al
    Autoimmune markers and vascular immune deposits in Finkelstein-Seidlmayer vasculitis: Systematic literature review.
    J Autoimmun. 2023;136:103002.
    PubMed     Abstract available
    
    
    
79. WESSELINGH R, Griffith S, Broadley J, Tarlinton D, et al
    Peripheral monocytes and soluble biomarkers in autoimmune encephalitis.
    J Autoimmun. 2023;135:103000.
    PubMed     Abstract available
    
    
    
80. LEE HJ, Lee SW, Cha HR, Ha EK, et al
    Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: A population-matched retrospective cohort study.
    J Autoimmun. 2023 Feb 1:102997. doi: 10.1016/j.jaut.2023.102997.
    PubMed     Abstract available
    
    
    
81. TEN HAGEN A, Hermann S, Habermann E, Frommert LM, et al
    Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients.
    J Autoimmun. 2023;135:102996.
    PubMed     Abstract available
    
    
    
82. IBTEHAJ N, Bahauddin A, Ivannikov M, Rytting E, et al
    B cell-specific mAb-siRNA conjugates improve experimental myasthenia.
    J Autoimmun. 2023;135:102983.
    PubMed     Abstract available
    
    
    
83. JACOBS ET, Catalfamo CJ, Colombo PM, Khan SM, et al
    Pre-existing conditions associated with post-acute sequelae of COVID-19.
    J Autoimmun. 2023;135:102991.
    PubMed     Abstract available
    
    
    January 2023
84. MATSUDA KM, Kotani H, Yamaguchi K, Okumura T, et al
    Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening.
    J Autoimmun. 2023;135:102995.
    PubMed     Abstract available
    
    
    
85. REYNOLDS JA, Putterman C
    Progress and unmet needs in understanding fundamental mechanisms of autoimmunity.
    J Autoimmun. 2023 Jan 29:102999. doi: 10.1016/j.jaut.2023.102999.
    PubMed     Abstract available
    
    
    
86. SVANBERG C, Enocsson H, Govender M, Martinsson K, et al
    Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type I interferon gene dysregulation.
    J Autoimmun. 2023;135:102998.
    PubMed     Abstract available
    
    
    
87. LYU Z, Huang B, Zhang J, Qian Q, et al
    Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.
    J Autoimmun. 2023;135:102993.
    PubMed     Abstract available
    
    
    
88. MIQUEL CH, Faz-Lopez B, Guery JC
    Influence of X chromosome in sex-biased autoimmune diseases.
    J Autoimmun. 2023 Jan 12:102992. doi: 10.1016/j.jaut.2023.102992.
    PubMed     Abstract available
    
    
    
89. VULSTEKE JB, Smith V, Bonroy C, Derua R, et al
    Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis.
    J Autoimmun. 2023;135:102988.
    PubMed     Abstract available
    
    
    
90. LOPEZ-PEDRERA C, Patino-Trives AM, Cerdo T, Ortega-Castro R, et al
    Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.
    J Autoimmun. 2023;135:102990.
    PubMed     Abstract available
    
    
    
91. LARON Z, Shulman L, Hampe C, Blumenfeld O, et al
    Hypothesis: Viral infections of pregnant women may be early triggers of childhood type 1 diabetes and other autoimmune disease.
    J Autoimmun. 2023;135:102977.
    PubMed     Abstract available
    
    
    
92. RAUBER S, Schroeter CB, Strippel C, Nelke C, et al
    Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis.
    J Autoimmun. 2023;135:102985.
    PubMed     Abstract available
    
    
    
93. ZHENG M, Zhou W, Huang C, Hu Z, et al
    A single-cell map of peripheral alterations after FMT treatment in patients with systemic lupus erythematosus.
    J Autoimmun. 2023;135:102989.
    PubMed     Abstract available
    
    
    
94. KUTSUNA YJ, Iwamoto N, Ichinose K, Aibara N, et al
    Immune complexome analysis of a rich variety of serum immune complexes identifies disease-characteristic immune complex antigens in systemic sclerosis.
    J Autoimmun. 2023;134:102954.
    PubMed     Abstract available
    
    
    December 2022
95. KUMAR D, Sahoo SS, Chauss D, Kazemian M, et al
    Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations.
    J Autoimmun. 2022;134:102982.
    PubMed     Abstract available
    
    
    
96. VERROU KM, Sfikakis PP, Tektonidou MG
    Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome.
    J Autoimmun. 2022;134:102978.
    PubMed     Abstract available
    
    
    
97. MAGEAU A, Tchen J, Ferre VM, Nicaise-Roland P, et al
    Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project.
    J Autoimmun. 2022;134:102987.
    PubMed     Abstract available
    
    
    
98. COSS SL, Zhou D, Chua GT, Aziz RA, et al
    The complement system and human autoimmune diseases.
    J Autoimmun. 2022 Dec 17:102979. doi: 10.1016/j.jaut.2022.102979.
    PubMed     Abstract available
    
    
    
99. MORA VP, Loaiza RA, Soto JA, Bohmwald K, et al
    Involvement of trained immunity during autoimmune responses.
    J Autoimmun. 2022 Dec 14:102956. doi: 10.1016/j.jaut.2022.102956.
    PubMed     Abstract available
    
    
    
100. WEI X, Niu X
     T follicular helper cells in autoimmune diseases.
     J Autoimmun. 2022;134:102976.
     PubMed     Abstract available
     
     
     
101. JOHNSON D, Jiang W
     Infectious diseases, autoantibodies, and autoimmunity.
     J Autoimmun. 2022 Dec 2:102962. doi: 10.1016/j.jaut.2022.102962.
     PubMed     Abstract available
     
     
     
102. PREGER C, Notarnicola A, Hellstrom C, Wigren E, et al
     Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
     J Autoimmun. 2022;134:102951.
     PubMed     Abstract available
     
     
     
103. EIZA N, Sabag AD, Kessler O, Neufeld G, et al
     CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus.
     J Autoimmun. 2022;134:102960.
     PubMed     Abstract available
     
     
     
104. SCURT FG, Bose K, Hammoud B, Brandt S, et al
     Old known and possible new biomarkers of ANCA-associated vasculitis.
     J Autoimmun. 2022;133:102953.
     PubMed     Abstract available
     
     
     November 2022
105. MA M, Santosa A, Fong W, Chew LC, et al
     Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
     J Autoimmun. 2022;134:102959.
     PubMed     Abstract available
     
     
     
106. LV J, Chen L, Zhao L
     Renoprotective anti-CD45RB antibody induces B cell production in systemic lupus erythematosus based on single-cell RNA-seq analysis.
     J Autoimmun. 2022;134:102949.
     PubMed     Abstract available
     
     
     
107. HOFFMAN K, Brownell Z, Doyle WJ, Ochoa-Reparaz J, et al
     The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model.
     J Autoimmun. 2022 Nov 23:102957. doi: 10.1016/j.jaut.2022.102957.
     PubMed     Abstract available
     
     
     
108. SHARFE N, Dalal I, Naghdi Z, Lefaudeux D, et al
     NFkappaB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity.
     J Autoimmun. 2022 Nov 16:102946. doi: 10.1016/j.jaut.2022.102946.
     PubMed     Abstract available
     
     
     
109. WILDNER G
     Antigenic mimicry - The key to autoimmunity in immune privileged organs.
     J Autoimmun. 2022 Nov 7:102942. doi: 10.1016/j.jaut.2022.102942.
     PubMed     Abstract available
     
     
     
110. CHENG Z, Hou G, Shen N
     Evolving understandings for the roles of non-coding RNAs in autoimmunity and autoimmune disease.
     J Autoimmun. 2022 Nov 7:102948. doi: 10.1016/j.jaut.2022.102948.
     PubMed     Abstract available
     
     
     
111. LIU Q, Zheng Y, Goronzy JJ, Weyand CM, et al
     T cell aging as a risk factor for autoimmunity.
     J Autoimmun. 2022 Nov 7:102947. doi: 10.1016/j.jaut.2022.102947.
     PubMed     Abstract available
     
     
     
112. BERRYMAN MA, Milletich PL, Petrone JR, Roesch LF, et al
     Autoimmune-associated genetics impact probiotic colonization of the infant gut.
     J Autoimmun. 2022;133:102943.
     PubMed     Abstract available
     
     
     
113. MEHLSEN J, Brinth L, Pors K, Varming K, et al
     Autoimmunity in patients reporting long-term complications after exposure to human papilloma virus vaccination.
     J Autoimmun. 2022;133:102921.
     PubMed    
     
     
     October 2022
114. ZENG L, Yang K, Zhang T, Zhu X, et al
     Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review.
     J Autoimmun. 2022;133:102919.
     PubMed     Abstract available
     
     
     
115. GERUSSI A, Soskic B, Asselta R, Invernizzi P, et al
     GWAS and autoimmunity: What have we learned and what next.
     J Autoimmun. 2022;133:102922.
     PubMed     Abstract available
     
     
     
116. HAKROUSH S, Tampe D, Baier E, Kluge IA, et al
     Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis.
     J Autoimmun. 2022;133:102924.
     PubMed     Abstract available
     
     
     
117. MIZRACHI M, Anderson E, Carroll KR, Tehrani N, et al
     Cognitive dysfunction in SLE: An understudied clinical manifestation.
     J Autoimmun. 2022;132:102911.
     PubMed     Abstract available
     
     
     
118. BAKHTIAR S, Kaffenberger C, Salzmann-Manrique E, Donhauser S, et al
     Regulatory B cells in patients suffering from inborn errors of immunity with severe immune dysregulation.
     J Autoimmun. 2022;132:102891.
     PubMed     Abstract available
     
     
     
119. BRUSCHI M, Angeletti A, Kajana X, Moroni G, et al
     Evidence for charge-based mimicry in anti dsDNA antibody generation.
     J Autoimmun. 2022;132:102900.
     PubMed     Abstract available
     
     
     
120. MAZ MP, Martens JWS, Hannoudi A, Reddy AL, et al
     Recent advances in cutaneous lupus.
     J Autoimmun. 2022;132:102865.
     PubMed     Abstract available
     
     
     
121. ARINGER M, Costenbader K, Dorner T, Johnson SR, et al
     Advances in SLE classification criteria.
     J Autoimmun. 2022;132:102845.
     PubMed     Abstract available
     
     
     September 2022
122. SJOGREN T, Bratland E, Royrvik EC, Grytaas MA, et al
     Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies.
     J Autoimmun. 2022;133:102917.
     PubMed     Abstract available
     
     
     
123. AENDEKERK JP, Jiemy WF, Raveling-Eelsing E, Bijnens N, et al
     CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis.
     J Autoimmun. 2022;133:102914.
     PubMed     Abstract available
     
     
     
124. BAKER KF, Skelton AJ, Lendrem DW, Scadeng A, et al
     Erratum to "Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study" [J. Autoimmun. 105 (December 2019) 102298].
     J Autoimmun. 2022 Sep 19:102913. doi: 10.1016/j.jaut.2022.102913.
     PubMed    
     
     
     
125. AZOULAY LD, Pineton de Chambrun M, Larcher R, Pene F, et al
     Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients.
     J Autoimmun. 2022;133:102908.
     PubMed     Abstract available
     
     
     
126. SCHOLZ GA, Fux M, Christ L, Iype J, et al
     Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis.
     J Autoimmun. 2022;133:102909.
     PubMed    
     
     
     
127. ALVAREZ D, Rua C, Velasquez Berrio M, Catano JU, et al
     Extracellular vesicles released upon stimulation with antiphospholipid antibodies: An actual direct procoagulant mechanism or a new factor in the lupus anticoagulant paradox?
     J Autoimmun. 2022;133:102905.
     PubMed     Abstract available
     
     
     
128. LI X, Zhang Y, Wang J, Li Y, et al
     zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis.
     J Autoimmun. 2022;133:102904.
     PubMed     Abstract available
     
     
     
129. SAKURABA K, Krishnamurthy A, Sun J, Zheng X, et al
     Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis.
     J Autoimmun. 2022;133:102903.
     PubMed     Abstract available
     
     
     
130. EFE C, Tascilar K, Gerussi A, Bolis F, et al
     SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
     J Autoimmun. 2022;132:102906.
     PubMed     Abstract available
     
     
     August 2022
131. CHEN K, Li Y, Yang H
     Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications.
     J Autoimmun. 2022;132:102895.
     PubMed     Abstract available
     
     
     
132. XIA Y, Jiang C, Yang M, Liu T, et al
     SB431542 alleviates lupus nephritis by regulating B cells and inhibiting the TLR9/TGFbeta1/PDGFB signaling.
     J Autoimmun. 2022;132:102894.
     PubMed     Abstract available
     
     
     
133. RODRIGUEZ Y, Rojas M, Beltran S, Polo F, et al
     Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.
     J Autoimmun. 2022;132:102898.
     PubMed     Abstract available
     
     
     
134. JIANING W, Jingyi X, Pingting Y
     Neuropsychiatric lupus erythematosus: Focusing on autoantibodies.
     J Autoimmun. 2022 Aug 24:102892. doi: 10.1016/j.jaut.2022.102892.
     PubMed     Abstract available
     
     
     
135. JIANG Y, Cheng Y, Ma S, Li T, et al
     Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.
     J Autoimmun. 2022 Aug 24:102887. doi: 10.1016/j.jaut.2022.102887.
     PubMed     Abstract available
     
     
     
136. ZHANG W, Shao T, Leung PSC, Tsuneyama K, et al
     Dual B-cell targeting therapy ameliorates autoimmune cholangitis.
     J Autoimmun. 2022;132:102897.
     PubMed     Abstract available
     
     
     
137. MYHR KA, Zinglersen AH, Hermansen MF, Jepsen MM, et al
     Left ventricular size and function in patients with systemic lupus erythematosus associate with lupus anticoagulant: An echocardiographic follow-up study.
     J Autoimmun. 2022;132:102884.
     PubMed     Abstract available
     
     
     
138. BEVILACQUA ROLFSEN FERREIRA DA, Pereira das Neves S, Roque Oliveira SC, Marques F, et al
     Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis.
     J Autoimmun. 2022;132:102893.
     PubMed     Abstract available
     
     
     
139. YU C, Li P, Dang X, Zhang X, et al
     Lupus nephritis: new progress in diagnosis and treatment.
     J Autoimmun. 2022 Aug 20:102871. doi: 10.1016/j.jaut.2022.102871.
     PubMed     Abstract available
     
     
     
140. NING W, Xu W, Cong X, Fan H, et al
     COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman.
     J Autoimmun. 2022;132:102896.
     PubMed     Abstract available
     
     
     
141. REILY C, Rice T, Crossman DK, Rizk DV, et al
     Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
     J Autoimmun. 2022;132:102883.
     PubMed     Abstract available
     
     
     
142. ROUSSELIN C, Amoura Z, Faguer S, Bataille P, et al
     Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy.
     J Autoimmun. 2022;132:102889.
     PubMed     Abstract available
     
     
     
143. XU Y, Li P, Li K, Li N, et al
     Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus.
     J Autoimmun. 2022 Aug 10:102890. doi: 10.1016/j.jaut.2022.102890.
     PubMed     Abstract available
     
     
     
144. ARBITMAN L, Furie R, Vashistha H
     B cell-targeted therapies in systemic lupus erythematosus.
     J Autoimmun. 2022 Aug 10:102873. doi: 10.1016/j.jaut.2022.102873.
     PubMed     Abstract available
     
     
     
145. IZAGIRRE A, Arzallus T, Garmendia M, Torrente S, et al
     Autoimmune hepatitis following COVID-19 vaccination.
     J Autoimmun. 2022;132:102874.
     PubMed    
     
     
     
146. SIDDIQI KZ, Zinglersen AH, Iversen KK, Rasmussen NS, et al
     A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus.
     J Autoimmun. 2022;132:102869.
     PubMed     Abstract available
     
     
     
147. CHEN Y, Lin J, Xiao L, Zhang X, et al
     Gut microbiota in systemic lupus erythematosus: A fuse and a solution.
     J Autoimmun. 2022;132:102867.
     PubMed     Abstract available
     
     
     July 2022
148. TAN Y, Yang S, Liu Q, Li Z, et al
     Pregnancy-related complications in systemic lupus erythematosus.
     J Autoimmun. 2022 Jul 21:102864. doi: 10.1016/j.jaut.2022.102864.
     PubMed     Abstract available
     
     
     
149. LOU H, Ling GS, Cao X
     Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target.
     J Autoimmun. 2022 Jul 21:102861. doi: 10.1016/j.jaut.2022.102861.
     PubMed     Abstract available
     
     
     
150. LI H, Boulougoura A, Endo Y, Tsokos GC, et al
     Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.
     J Autoimmun. 2022 Jul 21:102870. doi: 10.1016/j.jaut.2022.102870.
     PubMed     Abstract available
     
     
     
151. VIEIRA M, Comarmond C, Labreuche J, Mirouse A, et al
     COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
     J Autoimmun. 2022;132:102868.
     PubMed     Abstract available
     
     
     
152. LIU Y, Yu X, Zhang W, Zhang X, et al
     Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
     J Autoimmun. 2022 Jul 16:102863. doi: 10.1016/j.jaut.2022.102863.
     PubMed     Abstract available
     
     
     
153. FERRI C, Gragnani L, Raimondo V, Visentini M, et al
     Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
     J Autoimmun. 2022;131:102866.
     PubMed     Abstract available
     
     
     
154. NING W, Cheng D, Howe PH, Bian C, et al
     Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.
     J Autoimmun. 2022;131:102860.
     PubMed     Abstract available
     
     
     
155. HUANG C, Yi P, Zhu M, Zhou W, et al
     Erratum to "Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial" [J. Autoimmun. 130, June 2022, 102844].
     J Autoimmun. 2022;131:102862.
     PubMed    
     
     
     
156. NATARAJA C, Flynn J, Dankers W, Northcott M, et al
     GILZ regulates type I interferon release and sequesters STAT1.
     J Autoimmun. 2022;131:102858.
     PubMed     Abstract available
     
     
     
157. IYER VS, Boddul SV, Johnsson AK, Raposo B, et al
     Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2.
     J Autoimmun. 2022;131:102857.
     PubMed     Abstract available
     
     
     June 2022
158. LIU J, Zhang X, Cao X
     Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications.
     J Autoimmun. 2022 Jun 27:102856. doi: 10.1016/j.jaut.2022.102856.
     PubMed     Abstract available
     
     
     
159. BAKASIS AD, Mavragani CP, Voulgari PV, Gerolymatou N, et al
     COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
     J Autoimmun. 2022;131:102846.
     PubMed     Abstract available
     
     
     
160. HUANG C, Yi P, Zhu M, Zhou W, et al
     Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial.
     J Autoimmun. 2022 Jun 8:102844. doi: 10.1016/j.jaut.2022.102844.
     PubMed     Abstract available
     
     
     
161. WANG C, Zhou W, Liu Y, Xu Y, et al
     Nuclear translocation of RIG-I promotes cellular apoptosis.
     J Autoimmun. 2022;130:102840.
     PubMed     Abstract available
     
     
     May 2022
162. BUCCI T, Ames PR, Cammisotto V, Bartimoccia S, et al
     Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.
     J Autoimmun. 2022;129:102832.
     PubMed     Abstract available
     
     
     
163. FAN NW, Wang S, Ortiz G, Chauhan SK, et al
     Autoreactive memory Th17 cells are principally derived from T-bet(+)RORgammat(+) Th17/1 effectors.
     J Autoimmun. 2022;129:102816.
     PubMed     Abstract available
     
     
     April 2022
164. MELDERIS S, Warkotsch MT, Dang J, Hagenstein J, et al
     The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4(+) T helper cell responses.
     J Autoimmun. 2022;129:102829.
     PubMed     Abstract available
     
     
     
165. COUTANT F, Bachet R, Pin JJ, Alonzo M, et al
     Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production.
     J Autoimmun. 2022;130:102831.
     PubMed     Abstract available
     
     
     
166. LI X, Gao L, Tong X, Chan VKY, et al
     Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
     J Autoimmun. 2022;130:102830.
     PubMed     Abstract available
     
     
     March 2022
167. ZHAO Z, Zhu H, Li Q, Liao W, et al
     Skin CD4(+) Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases.
     J Autoimmun. 2022;128:102811.
     PubMed     Abstract available
     
     
     
168. CENTA M, Weinstein EG, Clemente JC, Faith JJ, et al
     Impaired central tolerance induces changes in the gut microbiota that exacerbate autoimmune hepatitis.
     J Autoimmun. 2022;128:102808.
     PubMed     Abstract available
     
     
     
169. TEKTONIDOU MG
     Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis.
     J Autoimmun. 2022;128:102813.
     PubMed     Abstract available
     
     
     February 2022
170. BOSTAN H, Ucan B, Kizilgul M, Calapkulu M, et al
     Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature.
     J Autoimmun. 2022;128:102809.
     PubMed     Abstract available
     
     
     
171. TIAN J, Zhou H, Fang D, Yi P, et al
     The global burden of heterogeneity of lupus erythematosus interventional trials.
     J Autoimmun. 2022;128:102798.
     PubMed     Abstract available
     
     
     
172. OHTO T, Tayeh AA, Nishikomori R, Abe H, et al
     Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis.
     J Autoimmun. 2022;127:102794.
     PubMed     Abstract available
     
     
     
173. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
     Corrigendum to "Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies" [J. Autoimmun. 126 (2022) 102774].
     J Autoimmun. 2022 Feb 9:102797. doi: 10.1016/j.jaut.2022.102797.
     PubMed    
     
     
     
174. VIEIRA M, Regnier P, Maciejewski-Duval A, Le Joncour A, et al
     Interferon signature in giant cell arteritis aortitis.
     J Autoimmun. 2022;127:102796.
     PubMed     Abstract available
     
     
     January 2022
175. HANSEN CHF, Larsen CS, Zachariassen LF, Mentzel CMJ, et al
     Gluten-free diet reduces autoimmune diabetes mellitus in mice across multiple generations in a microbiota-independent manner.
     J Autoimmun. 2022;127:102795.
     PubMed     Abstract available
     
     
     
176. PASSAM FH, Chen G, Chen VM, Qi M, et al
     Betaeta-2-glycoprotein I exerts antithrombotic function through its domain V in mice.
     J Autoimmun. 2022;126:102747.
     PubMed     Abstract available
     
     
     December 2021
177. AFRASIABI A, Keane JT, Ong LTC, Alinejad-Rokny H, et al
     Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.
     J Autoimmun. 2021;127:102781.
     PubMed     Abstract available
     
     
     
178. ROJAS M, Ramirez-Santana C, Acosta-Ampudia Y, Monsalve DM, et al
     New insights into the taxonomy of autoimmune diseases based on polyautoimmunity.
     J Autoimmun. 2021;126:102780.
     PubMed     Abstract available
     
     
     
179. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
     Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.
     J Autoimmun. 2021;126:102774.
     PubMed     Abstract available
     
     
     
180. MAHROUM N, Alghory A, Kiyak Z, Alwani A, et al
     Ferritin - from iron, through inflammation and autoimmunity, to COVID-19.
     J Autoimmun. 2021;126:102778.
     PubMed     Abstract available
     
     
     
181. RAIKER R, Pakhchanian H, DeYoung C, Gupta L, et al
     Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
     J Autoimmun. 2021;125:102730.
     PubMed     Abstract available
     
     
     November 2021
182. AVCI E, Abasiyanik F
     Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
     J Autoimmun. 2021;125:102745.
     PubMed     Abstract available
     
     
     
183. FERRI C, Ursini F, Gragnani L, Raimondo V, et al
     Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
     J Autoimmun. 2021;125:102744.
     PubMed     Abstract available
     
     
     
184. PADOAN R, Gatto M, Ghirardello A, Tonello M, et al
     IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
     J Autoimmun. 2021;124:102725.
     PubMed     Abstract available
     
     
     October 2021
185. TZIOUFAS AG, Bakasis AD, Goules AV, Bitzogli K, et al
     A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.
     J Autoimmun. 2021;125:102743.
     PubMed     Abstract available
     
     
     
186. HANSEN N, Krasiuk I, Titsch T
     Neural autoantibodies in delirium.
     J Autoimmun. 2021;125:102740.
     PubMed     Abstract available
     
     
     
187. GARRIDO I, Lopes S, Simoes MS, Liberal R, et al
     Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence.
     J Autoimmun. 2021;125:102741.
     PubMed     Abstract available
     
     
     
188. PATRIZIO A, Ferrari SM, Antonelli A, Fallahi P, et al
     A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination.
     J Autoimmun. 2021;125:102738.
     PubMed     Abstract available
     
     
     September 2021
189. GATTO M, Saccon F, Andreoli L, Bartoloni E, et al
     Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
     J Autoimmun. 2021;124:102729.
     PubMed     Abstract available
     
     
     
190. RELA M, Jothimani D, Vij M, Rajakumar A, et al
     Auto-immune hepatitis following COVID vaccination.
     J Autoimmun. 2021;123:102688.
     PubMed     Abstract available
     
     
     
191. BOGIE JFJ, Vanmierlo T, Vanmol J, Timmermans S, et al
     Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner.
     J Autoimmun. 2021;124:102723.
     PubMed     Abstract available
     
     
     
192. SALVIANO-SILVA A, Becker M, Augusto DG, Busch H, et al
     Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus.
     J Autoimmun. 2021;123:102705.
     PubMed     Abstract available
     
     
     
193. VALENTINE KM, Mullins GN, Davalos OA, Seow LW, et al
     CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties.
     J Autoimmun. 2021;123:102690.
     PubMed     Abstract available
     
     
     August 2021
194. LEE AYS, Reed JH, Gordon TP
     Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
     J Autoimmun. 2021;124:102724.
     PubMed     Abstract available
     
     
     
195. HIRSIGER JR, Tamborrini G, Harder D, Bantug GR, et al
     Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination.
     J Autoimmun. 2021;124:102714.
     PubMed     Abstract available
     
     
     
196. HEMED-SHAKED M, Cowman MK, Kim JR, Huang X, et al
     MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A.
     J Autoimmun. 2021;124:102713.
     PubMed     Abstract available
     
     
     
197. HANSEN RB, Simard JF, Faurschou M, Jacobsen S, et al
     Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population.
     J Autoimmun. 2021;123:102692.
     PubMed     Abstract available
     
     
     
198. LU Q, Long H, Chow S, Hidayat S, et al
     Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
     J Autoimmun. 2021;123:102707.
     PubMed     Abstract available
     
     
     
199. RAJENDRAN S, Quesada-Masachs E, Zilberman S, Graef M, et al
     IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.
     J Autoimmun. 2021;123:102708.
     PubMed     Abstract available
     
     
     
200. ZHANG P, Zhang Y, Pan M, Liu Z, et al
     Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage.
     J Autoimmun. 2021;122:102650.
     PubMed     Abstract available
     
     
     July 2021
201. VUILLE-LESSARD E, Montani M, Bosch J, Semmo N, et al
     Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
     J Autoimmun. 2021;123:102710.
     PubMed     Abstract available
     
     
     
202. ZHOU S, Li Q, Zhou S, Zhao M, et al
     A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells.
     J Autoimmun. 2021;123:102686.
     PubMed     Abstract available
     
     
     
203. IBANEZ-VEGA J, Vilchez C, Jimenez K, Guevara C, et al
     Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
     J Autoimmun. 2021;123:102702.
     PubMed     Abstract available
     
     
     
204. BAKASIS AD, Mavragani CP, Boki KA, Tzioufas AG, et al
     COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
     J Autoimmun. 2021;123:102687.
     PubMed     Abstract available
     
     
     
205. GHIELMETTI M, Schaufelberger HD, Mieli-Vergani G, Cerny A, et al
     Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
     J Autoimmun. 2021;123:102706.
     PubMed     Abstract available
     
     
     
206. GRAVER JC, Abdulahad W, van der Geest KSM, Heeringa P, et al
     Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
     J Autoimmun. 2021;123:102684.
     PubMed     Abstract available
     
     
     
207. REN HM, Lukacher AE, Rahman ZSM, Olsen NJ, et al
     New developments implicating IL-21 in autoimmune disease.
     J Autoimmun. 2021;122:102689.
     PubMed     Abstract available
     
     
     
208. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
     Corrigendum to "Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis" [J. Autoimmun. 119C (2021) 102629].
     J Autoimmun. 2021;121:102665.
     PubMed    
     
     
     
209. MCGONAGLE D, De Marco G, Bridgewood C
     Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
     J Autoimmun. 2021;121:102662.
     PubMed     Abstract available
     
     
     
210. DOTAN A, Shoenfeld Y
     Perspectives on vaccine induced thrombotic thrombocytopenia.
     J Autoimmun. 2021;121:102663.
     PubMed     Abstract available
     
     
     June 2021
211. MONSTED MO, Falck ND, Pedersen K, Buschard K, et al
     Intestinal permeability in type 1 diabetes: An updated comprehensive overview.
     J Autoimmun. 2021;122:102674.
     PubMed     Abstract available
     
     
     
212. LINGEL H, Meltendorf S, Billing U, Thurm C, et al
     Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
     J Autoimmun. 2021;122:102682.
     PubMed     Abstract available
     
     
     
213. DIANA T, Ungerer M, Wuster C, Fassbender J, et al
     A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
     J Autoimmun. 2021;122:102666.
     PubMed     Abstract available
     
     
     
214. GU Y, Merriman C, Guo Z, Jia X, et al
     Novel autoantibodies to the beta-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
     J Autoimmun. 2021;122:102677.
     PubMed     Abstract available
     
     
     
215. RODRIGUEZ-PEREZ AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al
     Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
     J Autoimmun. 2021;122:102683.
     PubMed     Abstract available
     
     
     
216. KRILIS M, Qi M, Ioannou Y, Zhang JY, et al
     Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
     J Autoimmun. 2021;122:102675.
     PubMed     Abstract available
     
     
     
217. KJELDSEN J, Nielsen J, Ellingsen T, Knudsen T, et al
     Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark.
     J Autoimmun. 2021;120:102632.
     PubMed     Abstract available
     
     
     
218. DE BRUYN CARLIER T, Badloe FMS, Ring J, Gutermuth J, et al
     Autoreactive T cells and their role in atopic dermatitis.
     J Autoimmun. 2021;120:102634.
     PubMed     Abstract available
     
     
     May 2021
219. NISHIMURA T, Okayasu T, Hosoi H, Kitahara T, et al
     Long-term (16-26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss.
     J Autoimmun. 2021;121:102664.
     PubMed     Abstract available
     
     
     
220. TAKESHITA M, Suzuki K, Nakazawa M, Kamata H, et al
     Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease.
     J Autoimmun. 2021;121:102661.
     PubMed     Abstract available
     
     
     
221. GRAHAM JJ, Longhi MS, Heneghan MA
     T helper cell immunity in pregnancy and influence on autoimmune disease progression.
     J Autoimmun. 2021;121:102651.
     PubMed     Abstract available
     
     
     
222. GHESQUIERE T, Ciudad M, Ramon A, Greigert H, et al
     Mucosal-associated invariant T cells in Giant Cell Arteritis.
     J Autoimmun. 2021;121:102652.
     PubMed     Abstract available
     
     
     
223. KIM JS, Kim IH, Byun JM, Chang JH, et al
     Population-based study on the association between autoimmune disease and lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.
     J Autoimmun. 2021;121:102647.
     PubMed     Abstract available
     
     
     
224. YANAOKA H, Nagafuchi Y, Hanata N, Takeshima Y, et al
     Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls.
     J Autoimmun. 2021;119:102617.
     PubMed     Abstract available
     
     
     
225. HEIKKILA N, Sormunen S, Mattila J, Harkonen T, et al
     Generation of self-reactive, shared T-cell receptor alpha chains in the human thymus.
     J Autoimmun. 2021;119:102616.
     PubMed     Abstract available
     
     
     
226. THANOU A, Jupe E, Purushothaman M, Niewold TB, et al
     Clinical disease activity and flare in SLE: Current concepts and novel biomarkers.
     J Autoimmun. 2021;119:102615.
     PubMed     Abstract available
     
     
     
227. HAMMINGER P, Marchetti L, Preglej T, Platzer R, et al
     Histone deacetylase 1 controls CD4(+) T cell trafficking in autoinflammatory diseases.
     J Autoimmun. 2021;119:102610.
     PubMed     Abstract available
     
     
     April 2021
228. VALENTI L, Griffini S, Lamorte G, Grovetti E, et al
     Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595].
     J Autoimmun. 2021;120:102646.
     PubMed    
     
     
     
229. WILHELM M, Bonam SR, Schall N, Bendorius M, et al
     Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus.
     J Autoimmun. 2021;120:102633.
     PubMed     Abstract available
     
     
     
230. WANG JY, Zhang W, Roehrl MW, Roehrl VB, et al
     An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
     J Autoimmun. 2021;120:102644.
     PubMed     Abstract available
     
     
     
231. VAN WIGCHEREN GF, Roelofs D, Figdor CG, Florez-Grau G, et al
     Three distinct tolerogenic CD14(+) myeloid cell types to actively manage autoimmune disease: Opportunities and challenges.
     J Autoimmun. 2021;120:102645.
     PubMed     Abstract available
     
     
     March 2021
232. HALPERT G, Watad A, Tsur AM, Dotan A, et al
     Autoimmune dysautonomia in women with silicone breast implants.
     J Autoimmun. 2021;120:102631.
     PubMed     Abstract available
     
     
     
233. BENKAHLA MA, Sabouri S, Kiosses WB, Rajendran S, et al
     HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.
     J Autoimmun. 2021;119:102628.
     PubMed     Abstract available
     
     
     February 2021
234. BERGLIN E, Mohammad AJ, Dahlqvist J, Johansson L, et al
     Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
     J Autoimmun. 2021;117:102579.
     PubMed     Abstract available
     
     
     
235. GARIMELLA MG, He C, Chen G, Li QZ, et al
     The B cell response to both protein and nucleic acid antigens displayed on apoptotic cells are dependent on endosomal pattern recognition receptors.
     J Autoimmun. 2021;117:102582.
     PubMed     Abstract available
     
     
     January 2021
236. PENG B, Temple BR, Yang J, Geng S, et al
     Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus.
     J Autoimmun. 2021;116:102561.
     PubMed     Abstract available
     
     
     September 2020
237. LOMBARDI A, Concepcion E, Hou H, Arib H, et al
     Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
     J Autoimmun. 2020 Sep 17:102543. doi: 10.1016/j.jaut.2020.102543.
     PubMed     Abstract available
     
     
     December 2019
238. SABOURI S, Benkahla MA, Kiosses WB, Rodriguez-Calvo T, et al
     Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.
     J Autoimmun. 2019 Dec 6:102378. doi: 10.1016/j.jaut.2019.102378.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.